Diabetes: lipid-lowering therapies for primary prevention of CVD (T2DM and 10% risk)
Update information
Minor changes since publication
September 2025: We updated the source guidance section to align with updated recommendations in NICE's guideline on cardiovascular disease that link to relevant technology appraisals.
ISBN: 978-1-4731-5472-8